65,437 trials
Nervous System Disorder · Genetic Syndrome
Primary: Mean Change From Baseline in Neurological Symptoms Assessed by Using International Cooperative Ataxia Rating Scale (ICARS) Score - ITT Population — -2.2; -3.4; -4.0…
Aging · Sedentary Lifestyle · Frailty
Primary: Skeletal Muscle Mitochondrial Respiration State 3; Baseline to 12-week Change. — 2.2; -0.8 pmol O2/s/mg DW — p=0.9017
Diabetes Mellitus Type 1
Primary: Number of Participants With Treatment Related Adverse Events — 1 Participants
Tobacco Use Cessation · Smoking Behaviors · Health Disparity
Primary: 7day Point Prevalence for Smoking — 78; 83 Participants
Neuroendocrine Tumors
Primary: Progression Free Survival (PFS) — 34 % of participants with response
Contraception
Primary: Interest BC4Teens Care — 231 Participants
Heart Failure
Primary: Number of Subjects With Adverse Events — 7; 4 Participants
Cognitive Impairment
Primary: Accuracy of VIZAMYL™ PET Image Interpretations Made by Clinical Readers — 83.25 Percentage of image interpretations
Alzheimer Disease · Cognitive Dysfunction · Mild Dementia
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 7 Participants
Non-Small Cell Lung Cancer
Primary: Pulmonary Function, Based on Changes in Tissue Elasticity Measured From 4DCT — 1.09; 1.13 ratio
Ankylosing Spondylitis
Primary: Percentage of Participants With Assessment of SpondyloArthritis International Society 40% Response Criteria (ASAS40) Response at Week 16 — 22.5; 44.8 percentage of…
Acne Vulgaris
Primary: Change From Baseline in Acne Symptom and Impact Scale Questionnaire (ASIS) Domain Score at Week 12 — 1.96; -0.77; 2.06; -1.01 Score on a Scale — p=<.0001
Traumatic Rib Fracture(s)
Primary: Maximum Inspired Volume — 2250; 1300 mL
Rectal Cancer
Primary: Percentage of Organ Preservation — 57 percentage of participants
Hip Fractures
Primary: Count of Participants With Acute Post-operative Transfusion of Packed Red Blood Cells. — 118; 111 Participants — p=0.966